Showing results (71-80 of 2,251) with videos related to
Sort By:
Pageof 226
The Journal of Cardiovascular Nursing|July 11, 2006
Clinical outcomes in metabolic syndromeRohit Bhatheja, Deepak L BhattExpert Opinion on Emerging Drugs|December 10, 2003
Advances in antiplatelet therapyHani Jneid, Deepak L BhattEuropean Heart Journal. Acute Cardiovascular Care|June 3, 2017
Practical considerations for cangrelor use in patients with acute coronary syndromesSergio Leonardi, Deepak L BhattContemporary Clinical Trials|April 18, 2022
Evaluating the evaluators - Developing evidence of quality oversight effectiveness for clinical trial monitoring: Source data verification, source data review, statistical monitoring, key risk indicators, and direct measure of high risk errorsPenelope Manasco, Deepak L BhattCanadian Journal of Diabetes|December 29, 2019
Mechanisms by Which Glucagon-Like-Peptide-1 Receptor Agonists and Sodium-Glucose Cotransporter-2 Inhibitors Reduce Cardiovascular Risk in Adults With Type 2 Diabetes MellitusAbhinav Sharma, Subodh VermaClinical Chemistry|March 27, 2013
Evolving role of microparticles in the pathophysiology of endothelial dysfunctionFina Lovren, Subodh Verma3 Biotech|September 10, 2019
A comprehensive analysis of the B3 superfamily identifies tissue-specific and stress-responsive genes in chickpea (Cicer arietinum L.)Subodh Verma, Sabhyata BhatiaFunctional & Integrative Genomics|December 19, 2018
Analysis of genes encoding seed storage proteins (SSPs) in chickpea (Cicer arietinum L.) reveals co-expressing transcription factors and a seed-specific promoterSubodh Verma, Sabhyata BhatiaAnnual Review of Physiology|November 16, 2020
Effects of SGLT2 Inhibitors on Kidney and Cardiovascular FunctionVolker Vallon, Subodh VermaThe Canadian Journal of Cardiology|January 15, 2021
When and How to Use Sodium-Glucose Cotransporter 2 Inhibitors in Patients With Heart Failure With Reduced Ejection Fraction or Chronic Kidney DiseaseEileen O'Meara, Subodh VermaPageof 226